Section 1
The 60-Second Resuscitation Card (First 5 Minutes)
0:00
Bedside Action & Exact Dosing
Verify Arrest & Initiate High-Performance CPR: Confirm unresponsiveness, apnea/agonal gasping, and simultaneous carotid pulse check (≤ 10 s). Start chest compressions at 100–120/min, depth 5–6 cm (2–2.4 in), allowing full chest recoil [1].
Equipment / Execution
Step stool, backboard, defibrillator pads placed in anterolateral or anteroposterior position.
Physiological & Mechanical Objective
Generate artificial cardiac output (25–30% of native CO) via the thoracic pump and cardiac pump mechanisms; full recoil prevents positive intrathoracic pressure from collapsing venous return (PRA) and preserves Coronary Perfusion Pressure (CPP ≥ 15 mmHg) [1].
0:30
Bedside Action & Exact Dosing
Rhythm Analysis & Immediate Defibrillation (VF/pVT): Charge defibrillator during compressions (pre-charging) to keep perishock pause < 5 s. Deliver 200 J Biphasic unsynchronized shock (or manufacturer maximum) and immediately resume compressions without pulse check [1].
Equipment / Execution
Biphasic defibrillator (Rectilinear or Truncated Exponential waveform); hands-free pads.
Physiological & Mechanical Objective
Depolarize a critical mass of fibrillating myocardium simultaneously to terminate chaotic re-entrant wavelets, allowing the sinoatrial (SA) node or intrinsic pacemaker to resume organized depolarization [1].
1:30
Bedside Action & Exact Dosing
Airway, Capnography & Vascular Access: Insert supraglottic airway (i-gel size 4 for 50–90 kg) or endotracheal tube (7.5–8.0 mm ID) with zero interruption to chest compressions (< 5 s pause if needed). Attach waveform ETCO₂; ventilate at 10 breaths/min (1 breath every 6 s) with VT 500 mL (6–7 mL/kg IBW) and 100% FiO₂. Place large-bore antecubital IV (18G) or Proximal Humeral IO [1,2].
Equipment / Execution
Waveform capnography adapter, BVM with PEEP valve, EZ-IO 45 mm yellow needle (humeral head).
Physiological & Mechanical Objective
Target ETCO₂ > 10–20 mmHg to confirm pulmonary blood flow (proxy for cardiac output). Avoid hyperventilation, which raises intrathoracic pressure, drops preload, and induces cerebral vasoconstriction. If PEA/Asystole, give Epinephrine 1 mg (10 mL of 1:10,000) IV/IO immediately [1,3].
3:00
Bedside Action & Exact Dosing
Second Rhythm Check, Shock #2 & Vasopressor: If persistent VF/pVT, deliver 200–360 J Biphasic shock, resume CPR, and administer Epinephrine 1 mg (10 mL of 1:10,000) IV/IO flushed with 20 mL NS (repeat q3–5 min) [1,3]. Perform subxiphoid/parasternal POCUS strictly during the < 10 s pulse check (CASA protocol).
Equipment / Execution
Crash cart Epinephrine 0.1 mg/mL prefilled syringe; POCUS phased-array probe (1–5 MHz).
Physiological & Mechanical Objective
α₁-adrenergic agonism vasoconstricts peripheral/splanchnic beds, elevating aortic diastolic pressure (PAoD) and driving blood into the coronary ostia during compression diastole (CPP = PAoD − PRA) [1,3].
5:00
Bedside Action & Exact Dosing
Third Rhythm Check, Shock #3 & Antiarrhythmic / DSD Evaluation: If refractory VF/pVT after 3rd shock, administer Amiodarone 300 mg IV/IO bolus (or Lidocaine 1–1.5 mg/kg [100 mg] IV/IO) [1,4]. Apply second defibrillator pads for Double Sequential External Defibrillation (DSED) or shift to Vector-Change (VC) anteroposterior pads; screen for ECPR eligibility [5,6].
Equipment / Execution
2 × 150 mg/3 mL Amiodarone vials; second defibrillator for DSED; ultrasound for femoral ECPR cannulation.
Physiological & Mechanical Objective
Amiodarone blocks myocardial IKr (K⁺ channels, Class III) and inactivated Na⁺ channels, prolonging Phase 3 repolarization and effective refractory period to prevent refibrillation [4]. DSED/VC alters the electrical vector to capture posterior left ventricular fibers missed by standard pads [5].
| Time | Bedside Action & Exact Dosing | Equipment / Execution | Physiological & Mechanical Objective |
|---|---|---|---|
| 0:00 | Verify Arrest & Initiate High-Performance CPR: Confirm unresponsiveness, apnea/agonal gasping, and simultaneous carotid pulse check (≤ 10 s). Start chest compressions at 100–120/min, depth 5–6 cm (2–2.4 in), allowing full chest recoil [1]. | Step stool, backboard, defibrillator pads placed in anterolateral or anteroposterior position. | Generate artificial cardiac output (25–30% of native CO) via the thoracic pump and cardiac pump mechanisms; full recoil prevents positive intrathoracic pressure from collapsing venous return (PRA) and preserves Coronary Perfusion Pressure (CPP ≥ 15 mmHg) [1]. |
| 0:30 | Rhythm Analysis & Immediate Defibrillation (VF/pVT): Charge defibrillator during compressions (pre-charging) to keep perishock pause < 5 s. Deliver 200 J Biphasic unsynchronized shock (or manufacturer maximum) and immediately resume compressions without pulse check [1]. | Biphasic defibrillator (Rectilinear or Truncated Exponential waveform); hands-free pads. | Depolarize a critical mass of fibrillating myocardium simultaneously to terminate chaotic re-entrant wavelets, allowing the sinoatrial (SA) node or intrinsic pacemaker to resume organized depolarization [1]. |
| 1:30 | Airway, Capnography & Vascular Access: Insert supraglottic airway (i-gel size 4 for 50–90 kg) or endotracheal tube (7.5–8.0 mm ID) with zero interruption to chest compressions (< 5 s pause if needed). Attach waveform ETCO₂; ventilate at 10 breaths/min (1 breath every 6 s) with VT 500 mL (6–7 mL/kg IBW) and 100% FiO₂. Place large-bore antecubital IV (18G) or Proximal Humeral IO [1,2]. | Waveform capnography adapter, BVM with PEEP valve, EZ-IO 45 mm yellow needle (humeral head). | Target ETCO₂ > 10–20 mmHg to confirm pulmonary blood flow (proxy for cardiac output). Avoid hyperventilation, which raises intrathoracic pressure, drops preload, and induces cerebral vasoconstriction. If PEA/Asystole, give Epinephrine 1 mg (10 mL of 1:10,000) IV/IO immediately [1,3]. |
| 3:00 | Second Rhythm Check, Shock #2 & Vasopressor: If persistent VF/pVT, deliver 200–360 J Biphasic shock, resume CPR, and administer Epinephrine 1 mg (10 mL of 1:10,000) IV/IO flushed with 20 mL NS (repeat q3–5 min) [1,3]. Perform subxiphoid/parasternal POCUS strictly during the < 10 s pulse check (CASA protocol). | Crash cart Epinephrine 0.1 mg/mL prefilled syringe; POCUS phased-array probe (1–5 MHz). | α₁-adrenergic agonism vasoconstricts peripheral/splanchnic beds, elevating aortic diastolic pressure (PAoD) and driving blood into the coronary ostia during compression diastole (CPP = PAoD − PRA) [1,3]. |
| 5:00 | Third Rhythm Check, Shock #3 & Antiarrhythmic / DSD Evaluation: If refractory VF/pVT after 3rd shock, administer Amiodarone 300 mg IV/IO bolus (or Lidocaine 1–1.5 mg/kg [100 mg] IV/IO) [1,4]. Apply second defibrillator pads for Double Sequential External Defibrillation (DSED) or shift to Vector-Change (VC) anteroposterior pads; screen for ECPR eligibility [5,6]. | 2 × 150 mg/3 mL Amiodarone vials; second defibrillator for DSED; ultrasound for femoral ECPR cannulation. | Amiodarone blocks myocardial IKr (K⁺ channels, Class III) and inactivated Na⁺ channels, prolonging Phase 3 repolarization and effective refractory period to prevent refibrillation [4]. DSED/VC alters the electrical vector to capture posterior left ventricular fibers missed by standard pads [5]. |
Section 2
What Happened & Why (Pathophysiology & Cellular/Hemodynamic Mechanics)
The Biophysical Equation of Resuscitation: Coronary Perfusion Pressure (CPP)
Myocardial blood flow occurs almost exclusively during diastole (the relaxation/decompression phase of CPR). The fundamental biophysical determinant of Return of Spontaneous Circulation (ROSC) is Coronary Perfusion Pressure (CPP):
CPP = Aortic Diastolic Pressure (PAoD) − Right Atrial Diastolic Pressure (PRA) [Target Threshold: CPP ≥ 15 mmHg]
In human and animal models, a threshold of CPP ≥ 15 mmHg is required to restore myocardial ATP synthesis and achieve ROSC; below 15 mmHg, defibrillation of VF almost universally degenerates into asystole or pulseless electrical activity (PEA) [1].
- Why Pausing Compressions Kills (Hagen-Poiseuille & Arterial Windkessel Runoff): During chest compressions, it takes 8 to 12 consecutive compressions to “prime the pump” and build sufficient PAoD via the elastic recoil of the aorta. The moment compressions pause (e.g., for prolonged intubation or pulse check), blood runs off into the low-resistance peripheral venous capacitance bed, and PAoD plummets to equilibrate with PRA within 3 to 5 seconds, dropping CPP to near zero.
- Why Incomplete Recoil & Hyperventilation Kill: Leaning on the chest wall or delivering excessive positive-pressure breaths (> 10 breaths/min) maintains elevated positive intrathoracic pressure during the decompression phase. This directly increases PRA (the subtracted variable in the CPP equation) and collapses the superior/inferior vena cava, abolishing preload and dropping CPP below the 15 mmHg survival threshold.
The 3-Phase Time-Sensitive Model of Ventricular Fibrillation (Weisfeldt & Becker)
- The Electrical Phase (0–4 Minutes): Myocardial ATP stores remain relatively preserved; fibrillating myocytes exhibit high-amplitude coarse VF waveforms. Immediate biphasic defibrillation achieves > 80% ROSC because the myocardium has sufficient metabolic reserve to resume mechanical contraction once electrically reset.
- The Circulatory Phase (4–10 Minutes): Depletion of high-energy phosphates (ATP and phosphocreatine), accumulation of intracellular H⁺ and inorganic phosphate (Pi), and failure of the sarcolemmal Na⁺/K⁺-ATPase pump lead to intracellular Na⁺ and Ca²⁺ overload via reverse-mode Na⁺/Ca²⁺ exchanger (NCX) activity. Defibrillation during this phase without prior high-quality CPR and α₁-mediated coronary perfusion washes out accumulated metabolic toxins poorly and results in post-shock asystole or refibrillation.
- The Metabolic Phase (> 10 Minutes): Prolonged global ischemia triggers opening of the mitochondrial permeability transition pore (mPTP), cytochrome c release, endothelial glycocalyx shedding, and systemic translocation of gut endotoxin. Once ROSC is achieved, a massive Post-Cardiac Arrest Syndrome (PCAS) ensues [7].
Pathophysiology of Post-Cardiac Arrest Syndrome (PCAS)
PCAS comprises four overlapping pathophysiological processes [7]:
- Post-Arrest Brain Injury: Driven by loss of cerebral autoregulation (normal Monro-Kellie & MAP plateau of 60–150 mmHg shifts rightward), reactive oxygen species (ROS) burst upon reperfusion (superoxide O₂•⁻ and peroxynitrite ONOO⁻), excitotoxic glutamate release activating NMDA receptors, intracellular Ca²⁺ influx, and microvascular no-reflow.
- Post-Arrest Myocardial Dysfunction (“Myocardial Stunning”): Global ischemia-reperfusion desensitizes cardiac troponin C to Ca²⁺, causing transient biventricular systolic and diastolic dysfunction that peaks at 8 to 24 hours post-ROSC and typically resolves by 48–72 hours if hemodynamically supported.
- Systemic Ischemia/Reperfusion Response: Endothelial activation, leukocyte adhesion, complement cascade activation, and a cytokine storm (IL-6, TNF-α) producing a “sepsis-like” vasoplegic state paired with disseminated microvascular thrombosis.
- Persistent Precipitating Pathology: Unresolved acute coronary occlusion (OMI), massive pulmonary embolism, tension pneumothorax, or toxic/metabolic derangement.
PATHOPHYSIOLOGICAL CASCADE OF CARDIAC ARREST & POST-ROSC SYNDROME (PCAS)
1. CIRCULATORY ARREST & CELLULAR HYPOXIA
Cessation of O₂ Delivery (DO₂ = CO × CaO₂ = 0) → Anaerobic Glycolysis (Lactate + H⁺ accumulation) → Intracellular ATP Depletion → Sarcolemmal Na⁺/K⁺-ATPase Pump Failure.
↓
2. IONIC COLLAPSE & MYOCARDIAL CONTRACTURE
Intracellular Na⁺ Surge → Reverse-Mode Na⁺/Ca²⁺ Exchanger (NCX) Activation → Cytosolic Ca²⁺ Overload → Myofilament Hypercontracture (“Stone Heart” if untreated or given exogenous Calcium).
↓
3. RESUSCITATION BIOPHYSICS: THE CORONARY PERFUSION EQUATION
CPP = Aortic Diastolic Pressure (PAoD) − Right Atrial Diastolic Pressure (PRA) ≥ 15 mmHg
- Epinephrine (α₁ agonism) + Continuous Compressions: Increases PAoD ↑
- Full Chest Recoil + Controlled Ventilation (10 breaths/min): Decreases PRA ↓
↓ (ROSC Achieved)
4. POST-CARDIAC ARREST SYNDROME (PCAS) — THE 4 PILLARS
Pillar 1: Brain Injury
Glutamate Excitotoxicity → NMDA Ca²⁺ Influx → mPTP Opening & ROS Burst. Right-shifted cerebral autoregulation (CBF becomes strictly MAP-dependent).
Pillar 2: Myocardial Stunning
Troponin-C Ca²⁺ Desensitization → Transient Biventricular Systolic/Diastolic Dysfunction peaking at 8–24 hours (reversible by 48–72 hours).
Pillar 3: Systemic I/R Response
Endothelial Glycocalyx Shedding + IL-6 / TNF-α Surge → Sepsis-like Vasoplegia + Microvascular Immunothrombosis.
Pillar 4: Persistent Precipitant
Unresolved Acute Coronary Occlusion (STEMI/OMI), Massive Pulmonary Embolism, Pericardial Tamponade, or Severe Toxic/Electrolyte Crisis.
Section 3
Diagnostic Strategy & Risk Stratification
Quantitative Waveform Capnography (ETCO₂)
Timing & Execution
Continuous upon SGA or ETT placement during CPR and post-ROSC [1].
Why Chosen (Pathophysiological Significance)
During constant ventilation, pulmonary CO₂ elimination is directly proportional to pulmonary blood flow (Cardiac Output). 3 Key Clinical Roles:
1. Confirms tracheal tube placement.
2. Monitors CPR quality (target > 10–20 mmHg).
3. Detects ROSC via an abrupt jump of ≥ 10 mmHg (often to 35–45 mmHg) before the next pulse check [1].
1. Confirms tracheal tube placement.
2. Monitors CPR quality (target > 10–20 mmHg).
3. Detects ROSC via an abrupt jump of ≥ 10 mmHg (often to 35–45 mmHg) before the next pulse check [1].
Sensitivity / Specificity Blind Spots & Traps
Trap 1 (Sodium Bicarbonate): IV NaHCO₃ converts to H₂O + CO₂ via carbonic anhydrase, transiently spiking ETCO₂ for 2–4 min (“false ROSC” spike).
Trap 2 (Epinephrine): High-dose Epinephrine decreases pulmonary microvascular perfusion while increasing MAP, transiently lowering ETCO₂ by 2–5 mmHg.
Trap 3 (Massive PE): Severe dead-space ventilation (↑ VD/VT) causes persistently low ETCO₂ despite strong compressions.
Trap 2 (Epinephrine): High-dose Epinephrine decreases pulmonary microvascular perfusion while increasing MAP, transiently lowering ETCO₂ by 2–5 mmHg.
Trap 3 (Massive PE): Severe dead-space ventilation (↑ VD/VT) causes persistently low ETCO₂ despite strong compressions.
CASA POCUS Protocol (Cardiac Arrest Sonographic Assessment)
Timing & Execution
Strictly during the < 10 s rhythm/pulse check; record a 6-second video clip and review after compressions resume.
Why Chosen (Pathophysiological Significance)
Rapidly identifies reversible mechanical causes in sequential steps:
• Step 1: Pericardial tamponade.
• Step 2: Right ventricular strain/dilation (Massive PE).
• Step 3: Lung sliding (Tension Pneumothorax) & FAST (Ruptured AAA/Ectopic).
• Differentiates True PEA (electrical activity + mechanical standstill) from Pseudo-PEA (profound shock with organized contraction but impalpable pulses).
• Step 1: Pericardial tamponade.
• Step 2: Right ventricular strain/dilation (Massive PE).
• Step 3: Lung sliding (Tension Pneumothorax) & FAST (Ruptured AAA/Ectopic).
• Differentiates True PEA (electrical activity + mechanical standstill) from Pseudo-PEA (profound shock with organized contraction but impalpable pulses).
Sensitivity / Specificity Blind Spots & Traps
Blind Spot (RV Dilation in Arrest): During prolonged cardiac arrest of any etiology, blood pools in the venous capacitance system and equilibrates across chambers, causing mild-to-moderate RV dilation. Do not diagnose Massive PE solely on a dilated RV after 15+ minutes of arrest unless accompanied by clinical history, DVT on femoral compression ultrasound, or visible clot-in-transit.
Intra-Arrest / Post-ROSC Blood Gas & Point-of- Care Labs
Timing & Execution
Drawn from femoral arterial line or venous access during CPR; mandatory immediately post-ROSC.
Why Chosen (Pathophysiological Significance)
Rapidly detects lethal metabolic precipitants: Hyperkalemia (K⁺ > 6.5 mmol/L), severe metabolic acidosis, hypoglycemia, or ionized hypocalcemia. Post-ROSC PaO₂ and PaCO₂ guide ventilator titration [1,7].
Sensitivity / Specificity Blind Spots & Traps
Venous vs. Arterial Paradox in CPR: During CPR, arterial blood gas (ABG) often shows near-normal or respiratory alkalemic pH and low PaCO₂ due to high ventilation-to-perfusion ratios in the lungs, whereas central venous blood gas (VBG) reveals profound hypercarbic and lactic acidemia (pH < 7.0, PvCO₂ > 70 mmHg), which more accurately reflects tissue-level intracellular acidosis.
Immediate Post- ROSC 12-Lead ECG (+ V3R–V4R, V7–V9)
Timing & Execution
Within 5 minutes of ROSC; repeat at 15–30 minutes if initial ECG shows nonspecific ischemia [7,8].
Why Chosen (Pathophysiological Significance)
Identifies ST-Elevation Myocardial Infarction (STEMI) or Occlusion Myocardial Infarction (OMI) equivalents (hyperacute T waves, de Winter T waves, Shark Fin morphology, new LBBB with positive Sgarbossa criteria) requiring emergent PCI [7,8].
Sensitivity / Specificity Blind Spots & Traps
Immediate Post-ROSC False Positives: In the first 5–10 minutes after ROSC, severe global metabolic acidosis, catecholamine boluses, and defibrillation shocks can cause transient ST-segment elevations that resolve once perfusion and acid-base status normalize. However, persistent ST elevation warrants immediate cath lab activation [8].
Non-Contrast Head CT & CTPA / Pan-CT
Timing & Execution
Performed post-ROSC after hemodynamic stabilization (if no STEMI on ECG).
Why Chosen (Pathophysiological Significance)
Excludes Subarachnoid Hemorrhage (SAH)—which frequently presents as sudden cardiac arrest with secondary neurogenic ST elevations (“cerebral T waves” / Takotsubo)—and diagnoses Massive Pulmonary Embolism or occult aortic dissection [7].
Sensitivity / Specificity Blind Spots & Traps
Trap: Sending a post-ROSC patient with neurogenic stunned myocardium from a ruptured berry aneurysm directly to the cath lab for heparin and dual antiplatelet therapy (DAPT) without a rapid head CT results in catastrophic intracranial hemorrhage expansion.
| Diagnostic Modality | Timing & Execution | Why Chosen (Pathophysiological Significance) | Sensitivity / Specificity Blind Spots & Traps |
|---|---|---|---|
| Quantitative Waveform Capnography (ETCO₂) | Continuous upon SGA or ETT placement during CPR and post-ROSC [1]. | During constant ventilation, pulmonary CO₂ elimination is directly proportional to pulmonary blood flow (Cardiac Output). 3 Key Clinical Roles: 1. Confirms tracheal tube placement. 2. Monitors CPR quality (target > 10–20 mmHg). 3. Detects ROSC via an abrupt jump of ≥ 10 mmHg (often to 35–45 mmHg) before the next pulse check [1]. | Trap 1 (Sodium Bicarbonate): IV NaHCO₃ converts to H₂O + CO₂ via carbonic anhydrase, transiently spiking ETCO₂ for 2–4 min (“false ROSC” spike). Trap 2 (Epinephrine): High-dose Epinephrine decreases pulmonary microvascular perfusion while increasing MAP, transiently lowering ETCO₂ by 2–5 mmHg. Trap 3 (Massive PE): Severe dead-space ventilation (↑ VD/VT) causes persistently low ETCO₂ despite strong compressions. |
| CASA POCUS Protocol (Cardiac Arrest Sonographic Assessment) | Strictly during the < 10 s rhythm/pulse check; record a 6-second video clip and review after compressions resume. | Rapidly identifies reversible mechanical causes in sequential steps: • Step 1: Pericardial tamponade. • Step 2: Right ventricular strain/dilation (Massive PE). • Step 3: Lung sliding (Tension Pneumothorax) & FAST (Ruptured AAA/Ectopic). • Differentiates True PEA (electrical activity + mechanical standstill) from Pseudo-PEA (profound shock with organized contraction but impalpable pulses). | Blind Spot (RV Dilation in Arrest): During prolonged cardiac arrest of any etiology, blood pools in the venous capacitance system and equilibrates across chambers, causing mild-to-moderate RV dilation. Do not diagnose Massive PE solely on a dilated RV after 15+ minutes of arrest unless accompanied by clinical history, DVT on femoral compression ultrasound, or visible clot-in-transit. |
| Intra-Arrest / Post-ROSC Blood Gas & Point-of- Care Labs | Drawn from femoral arterial line or venous access during CPR; mandatory immediately post-ROSC. | Rapidly detects lethal metabolic precipitants: Hyperkalemia (K⁺ > 6.5 mmol/L), severe metabolic acidosis, hypoglycemia, or ionized hypocalcemia. Post-ROSC PaO₂ and PaCO₂ guide ventilator titration [1,7]. | Venous vs. Arterial Paradox in CPR: During CPR, arterial blood gas (ABG) often shows near-normal or respiratory alkalemic pH and low PaCO₂ due to high ventilation-to-perfusion ratios in the lungs, whereas central venous blood gas (VBG) reveals profound hypercarbic and lactic acidemia (pH < 7.0, PvCO₂ > 70 mmHg), which more accurately reflects tissue-level intracellular acidosis. |
| Immediate Post- ROSC 12-Lead ECG (+ V3R–V4R, V7–V9) | Within 5 minutes of ROSC; repeat at 15–30 minutes if initial ECG shows nonspecific ischemia [7,8]. | Identifies ST-Elevation Myocardial Infarction (STEMI) or Occlusion Myocardial Infarction (OMI) equivalents (hyperacute T waves, de Winter T waves, Shark Fin morphology, new LBBB with positive Sgarbossa criteria) requiring emergent PCI [7,8]. | Immediate Post-ROSC False Positives: In the first 5–10 minutes after ROSC, severe global metabolic acidosis, catecholamine boluses, and defibrillation shocks can cause transient ST-segment elevations that resolve once perfusion and acid-base status normalize. However, persistent ST elevation warrants immediate cath lab activation [8]. |
| Non-Contrast Head CT & CTPA / Pan-CT | Performed post-ROSC after hemodynamic stabilization (if no STEMI on ECG). | Excludes Subarachnoid Hemorrhage (SAH)—which frequently presents as sudden cardiac arrest with secondary neurogenic ST elevations (“cerebral T waves” / Takotsubo)—and diagnoses Massive Pulmonary Embolism or occult aortic dissection [7]. | Trap: Sending a post-ROSC patient with neurogenic stunned myocardium from a ruptured berry aneurysm directly to the cath lab for heparin and dual antiplatelet therapy (DAPT) without a rapid head CT results in catastrophic intracranial hemorrhage expansion. |
Section 4
Step-by-Step Management, Mixing Recipes, Special Populations & "Never Do This"
A. Master Therapeutic & Escalation Table
Non-Shockable Arrest (PEA / Asystole)
First-Line Drug / Intervention & Exact Dose
Epinephrine: 1 mg (10 mL of 0.1 mg/mL [1:10,000]) IV/IO push immediately upon access; repeat every 3–5 min [1,3].
Second-Line / Escalation & Ceiling Dose
Address H’s and T’s aggressively; consider Vasopressin 20 IU IV + Methylprednisolone 40 mg IV (VSE protocol in in-hospital arrest if applicable).
Receptor Pharmacology & Downstream Hemodynamic / Cellular Effect
Potent α₁-adrenergic receptor stimulation constricts vascular smooth muscle via Gq-PLC-IP₃ signaling, elevating systemic vascular resistance (SVR) and PAoD, thereby increasing CPP [3].
Shockable Arrest (Refractory VF / pVT)
First-Line Drug / Intervention & Exact Dose
Defibrillation: 200 J Biphasic.
Epinephrine: 1 mg IV/IO after the 2nd shock, repeat q3–5 min.
Amiodarone: 300 mg IV/IO bolus after the 3rd shock [1,4].
Epinephrine: 1 mg IV/IO after the 2nd shock, repeat q3–5 min.
Amiodarone: 300 mg IV/IO bolus after the 3rd shock [1,4].
Second-Line / Escalation & Ceiling Dose
Second Amiodarone Dose: 150 mg IV/IO after 5th shock (Max cumulative arrest bolus: 450 mg). Alternative: Lidocaine 1– 1.5 mg/kg IV/IO after 3rd shock, then 0.5–0.75 mg/kg (Max 3 mg/kg) [1,4].
Receptor Pharmacology & Downstream Hemodynamic / Cellular Effect
Amiodarone: Blocks IKr (K⁺ efflux) and inactivated fast Na⁺ channels + non-competitive β-blockade; stabilizes hyperexcitable ischemic ventricular myocardium.
Lidocaine: Class IB Na⁺ channel blocker with fast on/off kinetics; selectively binds depolarized ischemic tissue [4].
Lidocaine: Class IB Na⁺ channel blocker with fast on/off kinetics; selectively binds depolarized ischemic tissue [4].
Polymorphous VT / Torsades de Pointes (TdP)
First-Line Drug / Intervention & Exact Dose
Magnesium Sulfate (MgSO₄): 2 g (4 mL of 50% solution diluted in 10 mL D5W/NS) IV/IO push over 1–2 min [1].
Second-Line / Escalation & Ceiling Dose
Calcium Chloride 10%: 1 g (10 mL) if hyperkalemic. Post-ROSC: Isoproterenol infusion (2–10 mcg/min) or overdrive pacing to HR 100–110 bpm (acquired LQTS).
Receptor Pharmacology & Downstream Hemodynamic / Cellular Effect
Suppresses Early Afterdepolarizations (EADs) during Phase 2/3 of the cardiac action potential by inhibiting L-type Ca²⁺ channels across the myocardial sarcolemma, preventing reentry despite prolonged QT [1].
Hyperkalemic Arrest (K⁺ > 6.5 mmol/L)
First-Line Drug / Intervention & Exact Dose
Calcium Chloride 10%: 1 g (10 mL = 270 mg elemental Ca²⁺) IV/IO push over 1–2 min (or Calcium Gluconate 10% 3 g [30 mL]) [1].
Second-Line / Escalation & Ceiling Dose
Sodium Bicarbonate 8.4%: 50–100 mEq (50– 100 mL) IV push. Regular Insulin 10 Units IV + Dextrose 50% 50 mL (25 g) IV push.
Receptor Pharmacology & Downstream Hemodynamic / Cellular Effect
Ca²⁺: Restores the transmembrane voltage gradient by making the threshold potential less negative, directly antagonizing K⁺-induced sodium channel inactivation.
Insulin/NaHCO₃: Activates Na⁺/K⁺-ATPase and Na⁺/H⁺ antiporter to shift K⁺ intracellularly [1].
Insulin/NaHCO₃: Activates Na⁺/K⁺-ATPase and Na⁺/H⁺ antiporter to shift K⁺ intracellularly [1].
Confirmed or High-Suspicion Massive PE Arrest
First-Line Drug / Intervention & Exact Dose
Alteplase (tPA): 50 mg IV/IO bolus over 1 min (may repeat 50 mg bolus in 15 min if no ROSC; Max 100 mg) OR
Tenecteplase (TNK): 0.5 mg/kg IV bolus (Max 50 mg) [1].
Tenecteplase (TNK): 0.5 mg/kg IV bolus (Max 50 mg) [1].
Second-Line / Escalation & Ceiling Dose
Continue CPR for at least 60–90 minutes post-thrombolytic administration to allow mechanical circulation and enzymatic fibrinolysis of the saddle embolus.
Receptor Pharmacology & Downstream Hemodynamic / Cellular Effect
Binds fibrin in the pulmonary arterial thrombus and converts plasminogen to plasmin, cleaving cross-linked fibrin strands to relieve acute right ventricular outflow tract (RVOT) obstruction and restore LV preload.
Post-ROSC Hemodynamic Optimization
First-Line Drug / Intervention & Exact Dose
Norepinephrine: 0.05–0.5 mcg/kg/min IV/IO infusion + crystalloid bolus 500–1000 mL (unless pulmonary edema). Target MAP ≥ 65–75 mmHg (or ≥ 80 mmHg if cerebral edema/chronic HTN) [7].
Second-Line / Escalation & Ceiling Dose
Epinephrine infusion: 0.05–0.5 mcg/kg/min OR
Dobutamine: 2–20 mcg/kg/min if POCUS shows severe post-arrest myocardial stunning (LVEF < 30%) [7].
Dobutamine: 2–20 mcg/kg/min if POCUS shows severe post-arrest myocardial stunning (LVEF < 30%) [7].
Receptor Pharmacology & Downstream Hemodynamic / Cellular Effect
Norepinephrine provides potent α₁ vasoconstriction to counter PCAS vasoplegia and mild β₁ inotropy without excessive tachycardia or arrhythmogenesis compared to dopamine or high-dose epinephrine.
Post-ROSC Oxygenation, Ventilation & TTM
First-Line Drug / Intervention & Exact Dose
Ventilation: Target SpO₂ 92– 98% (PaO₂ 60–100 mmHg) and normocapnia (PaCO₂ 35–45 mmHg) [7].
Temperature Control (TTM): Actively prevent fever (≤ 37.5°C) or target 33–36°C for ≥ 24–72 hours in comatose survivors [7,9].
Temperature Control (TTM): Actively prevent fever (≤ 37.5°C) or target 33–36°C for ≥ 24–72 hours in comatose survivors [7,9].
Second-Line / Escalation & Ceiling Dose
Sedation with Propofol (20–50 mcg/kg/min) + Fentanyl (50–100 mcg/hr); suppress shivering with Buspirone 30 mg NG, Magnesium 2 g IV, or neuromuscular blockade (Cisatracurium).
Receptor Pharmacology & Downstream Hemodynamic / Cellular Effect
Avoiding hyperoxia (PaO₂ > 300 mmHg) prevents mitochondrial superoxide generation. Maintaining normocapnia prevents hypocapnic cerebral vasoconstriction (ischemia) and hypercapnic vasodilation (↑ ICP). Fever control reduces cerebral metabolic rate of oxygen (CMRO₂) by 7% per 1°C [7,9].
| Clinical Phase / Indication | First-Line Drug / Intervention & Exact Dose | Second-Line / Escalation & Ceiling Dose | Receptor Pharmacology & Downstream Hemodynamic / Cellular Effect |
|---|---|---|---|
| Non-Shockable Arrest (PEA / Asystole) | Epinephrine: 1 mg (10 mL of 0.1 mg/mL [1:10,000]) IV/IO push immediately upon access; repeat every 3–5 min [1,3]. | Address H’s and T’s aggressively; consider Vasopressin 20 IU IV + Methylprednisolone 40 mg IV (VSE protocol in in-hospital arrest if applicable). | Potent α₁-adrenergic receptor stimulation constricts vascular smooth muscle via Gq-PLC-IP₃ signaling, elevating systemic vascular resistance (SVR) and PAoD, thereby increasing CPP [3]. |
| Shockable Arrest (Refractory VF / pVT) | Defibrillation: 200 J Biphasic. Epinephrine: 1 mg IV/IO after the 2nd shock, repeat q3–5 min. Amiodarone: 300 mg IV/IO bolus after the 3rd shock [1,4]. | Second Amiodarone Dose: 150 mg IV/IO after 5th shock (Max cumulative arrest bolus: 450 mg). Alternative: Lidocaine 1– 1.5 mg/kg IV/IO after 3rd shock, then 0.5–0.75 mg/kg (Max 3 mg/kg) [1,4]. | Amiodarone: Blocks IKr (K⁺ efflux) and inactivated fast Na⁺ channels + non-competitive β-blockade; stabilizes hyperexcitable ischemic ventricular myocardium. Lidocaine: Class IB Na⁺ channel blocker with fast on/off kinetics; selectively binds depolarized ischemic tissue [4]. |
| Polymorphous VT / Torsades de Pointes (TdP) | Magnesium Sulfate (MgSO₄): 2 g (4 mL of 50% solution diluted in 10 mL D5W/NS) IV/IO push over 1–2 min [1]. | Calcium Chloride 10%: 1 g (10 mL) if hyperkalemic. Post-ROSC: Isoproterenol infusion (2–10 mcg/min) or overdrive pacing to HR 100–110 bpm (acquired LQTS). | Suppresses Early Afterdepolarizations (EADs) during Phase 2/3 of the cardiac action potential by inhibiting L-type Ca²⁺ channels across the myocardial sarcolemma, preventing reentry despite prolonged QT [1]. |
| Hyperkalemic Arrest (K⁺ > 6.5 mmol/L) | Calcium Chloride 10%: 1 g (10 mL = 270 mg elemental Ca²⁺) IV/IO push over 1–2 min (or Calcium Gluconate 10% 3 g [30 mL]) [1]. | Sodium Bicarbonate 8.4%: 50–100 mEq (50– 100 mL) IV push. Regular Insulin 10 Units IV + Dextrose 50% 50 mL (25 g) IV push. | Ca²⁺: Restores the transmembrane voltage gradient by making the threshold potential less negative, directly antagonizing K⁺-induced sodium channel inactivation. Insulin/NaHCO₃: Activates Na⁺/K⁺-ATPase and Na⁺/H⁺ antiporter to shift K⁺ intracellularly [1]. |
| Confirmed or High-Suspicion Massive PE Arrest | Alteplase (tPA): 50 mg IV/IO bolus over 1 min (may repeat 50 mg bolus in 15 min if no ROSC; Max 100 mg) OR Tenecteplase (TNK): 0.5 mg/kg IV bolus (Max 50 mg) [1]. | Continue CPR for at least 60–90 minutes post-thrombolytic administration to allow mechanical circulation and enzymatic fibrinolysis of the saddle embolus. | Binds fibrin in the pulmonary arterial thrombus and converts plasminogen to plasmin, cleaving cross-linked fibrin strands to relieve acute right ventricular outflow tract (RVOT) obstruction and restore LV preload. |
| Post-ROSC Hemodynamic Optimization | Norepinephrine: 0.05–0.5 mcg/kg/min IV/IO infusion + crystalloid bolus 500–1000 mL (unless pulmonary edema). Target MAP ≥ 65–75 mmHg (or ≥ 80 mmHg if cerebral edema/chronic HTN) [7]. | Epinephrine infusion: 0.05–0.5 mcg/kg/min OR Dobutamine: 2–20 mcg/kg/min if POCUS shows severe post-arrest myocardial stunning (LVEF < 30%) [7]. | Norepinephrine provides potent α₁ vasoconstriction to counter PCAS vasoplegia and mild β₁ inotropy without excessive tachycardia or arrhythmogenesis compared to dopamine or high-dose epinephrine. |
| Post-ROSC Oxygenation, Ventilation & TTM | Ventilation: Target SpO₂ 92– 98% (PaO₂ 60–100 mmHg) and normocapnia (PaCO₂ 35–45 mmHg) [7]. Temperature Control (TTM): Actively prevent fever (≤ 37.5°C) or target 33–36°C for ≥ 24–72 hours in comatose survivors [7,9]. | Sedation with Propofol (20–50 mcg/kg/min) + Fentanyl (50–100 mcg/hr); suppress shivering with Buspirone 30 mg NG, Magnesium 2 g IV, or neuromuscular blockade (Cisatracurium). | Avoiding hyperoxia (PaO₂ > 300 mmHg) prevents mitochondrial superoxide generation. Maintaining normocapnia prevents hypocapnic cerebral vasoconstriction (ischemia) and hypercapnic vasodilation (↑ ICP). Fever control reduces cerebral metabolic rate of oxygen (CMRO₂) by 7% per 1°C [7,9]. |
B. Crash-Cart Mixing & Drip-Titration Box (Arithmetically Verified)
CRASH-CART PREPARATION & INFUSION PUMP RECIPES
1. Push-Dose Epinephrine (10 mcg/mL) — For Peri-Arrest Hypotension or Immediate Post-ROSC Crash:
- Preparation: Take a 10 mL syringe filled with 9 mL of 0.9% Normal Saline. Draw up 1 mL of Cardiac Arrest Epinephrine (0.1 mg/mL [1:10,000] crash-cart prefilled syringe) into the syringe.
- Final Concentration: 100 mcg in 10 mL = 10 mcg/mL.
- Bedside Execution: Administer 0.5 to 2 mL (5–20 mcg) IV push every 2–5 minutes to bridge to central/peripheral vasopressor infusion.
2. Norepinephrine Continuous Infusion — First-Line Post-ROSC Shock:
- Preparation: Add 4 mg (1 ampule of 4 mg/4 mL) of Norepinephrine into 250 mL of D5W or NS.
- Final Concentration: 4,000 mcg ÷ 250 mL = 16 mcg/mL.
- Pump Rate Conversion (for an 80 kg Adult):
- 0.05 mcg/kg/min (4 mcg/min): 4 mcg/min × 60 min/hr = 240 mcg/hr ÷ 16 mcg/mL = 15 mL/hr.
- 0.10 mcg/kg/min (8 mcg/min): 8 mcg/min × 60 min/hr = 480 mcg/hr ÷ 16 mcg/mL = 30 mL/hr.
- 0.25 mcg/kg/min (20 mcg/min): 20 mcg/min × 60 min/hr = 1,200 mcg/hr ÷ 16 mcg/mL = 75 mL/hr.
3. Epinephrine Continuous Infusion — Post-ROSC Bradycardic / Cardiogenic Shock:
- Preparation: Add 4 mg (4 ampules of 1 mg/mL [1:1,000]) of Epinephrine into 250 mL of NS or D5W.
- Final Concentration: 4,000 mcg ÷ 250 mL = 16 mcg/mL.
- Pump Rate Conversion (for an 80 kg Adult): 0.05 mcg/kg/min = 15 mL/hr | 0.10 mcg/kg/min = 30 mL/hr | 0.20 mcg/kg/min = 60 mL/hr.
4. Post-ROSC Amiodarone Maintenance Infusion (After VF/pVT Arrest):
- Preparation: Add 450 mg (3 vials of 150 mg/3 mL) of Amiodarone into 250 mL of D5W (in a polyolefin/glass bottle).
- Final Concentration: 450 mg ÷ 250 mL = 1.8 mg/mL.
- Pump Rate Execution: First 6 Hours (1 mg/min = 60 mg/hr): 60 mg/hr ÷ 1.8 mg/mL = 33.3 mL/hr | Next 18 Hours (0.5 mg/min = 30 mg/hr): 30 mg/hr ÷ 1.8 mg/mL = 16.7 mL/hr.
C. The Refractory Crashing Patient (Minute 15–30 Salvage & Resource-Limited Bailouts)
When VF/pVT persists beyond 3 shocks, Epinephrine, and Amiodarone 300 mg (Refractory Ventricular Fibrillation):
- Vector-Change (VC) Defibrillation & Double Sequential External Defibrillation (DSED) [DOSE-VF Trial]:
- Vector-Change: Move pads from standard anterolateral (AL) to anteroposterior (AP) position (anterior pad over left precordium, posterior pad inferior to left scapula) to capture the posteriorly oriented left ventricular apex [5].
- DSED Execution: Keep the first set of pads in AL position and apply a second set of pads in AP position connected to a second defibrillator. Have a single operator press both “Shock” buttons sequentially with a < 1 second delay (so the two 200 J waveforms overlap temporally without damaging the defibrillator capacitors; avoid simultaneous 0 ms firing) [5].
- Esmolol Blockade for Sympathetic Storm (“Electrical Storm”): After multiple doses of exogenous Epinephrine and endogenous catecholamine release, myocardial β₁-receptors are hyperstimulated, lowering the fibrillation threshold and increasing myocardial oxygen consumption (MVO₂). Administer Esmolol 500 mcg/kg IV bolus over 1 minute, followed by an infusion at 50–100 mcg/kg/min, and halt further Epinephrine boluses to allow β₁ receptor stabilization and successful defibrillation.
- Stellate Ganglion Block (Ultrasound-Guided): In refractory electrical storm unresponsive to Esmolol and DSED, inject 10 mL of 0.5% Bupivacaine (or 1% Lidocaine) anterior to the longus colli muscle at the C6 (Chassaignac) tubercle under ultrasound guidance to block sympathetic outflow to the myocardium.
- Extracorporeal CPR (ECPR / VA-ECMO) Activation [ARREST Trial Criteria]: Activate immediately at Minute 10–15 (after 3 failed shocks) if the patient meets inclusion criteria: Age < 65–70 years, witnessed arrest with bystander CPR, initial shockable rhythm (VF/pVT), ETCO₂ > 10 mmHg during CPR, and ability to achieve femoral veno-arterial cannulation within 60 minutes of arrest onset [6].
D. Vulnerable Physiological Extremes Matrix (Pregnancy, Pediatrics & Geriatrics)
Pregnancy (≥ 20 Weeks Gestation / Fundus at or above Umbilicus)
Critical Physiological Difference
Gravid uterus compresses the inferior vena cava (IVC) and abdominal aorta in the supine position (aortocaval compression), reducing venous return and cardiac output by up to 60%, rendering standard chest compressions ineffective.
Mandatory Resuscitation & Dosing Modifications
1. Continuous Manual Left Uterine Displacement (LUD): Pull or push the uterus 15–30° to the left while keeping the thorax flat on the board for optimal compression vector [1].
2. IV Access Above the Diaphragm: Place IV/IO in upper extremities/humerus; femoral drugs are trapped below the compressed IVC.
3. Early Intubation with Smaller ETT: Airway edema requires a 6.0–6.5 mm ID ETT.
4. Resuscitative Hysterotomy (Perimortem C-Section): Prepare scalpel at Minute 0; incise at Minute 4 to deliver the fetus by Minute 5 if no ROSC. Relieves IVC compression and increases maternal cardiac output by 30–50% [1].
2. IV Access Above the Diaphragm: Place IV/IO in upper extremities/humerus; femoral drugs are trapped below the compressed IVC.
3. Early Intubation with Smaller ETT: Airway edema requires a 6.0–6.5 mm ID ETT.
4. Resuscitative Hysterotomy (Perimortem C-Section): Prepare scalpel at Minute 0; incise at Minute 4 to deliver the fetus by Minute 5 if no ROSC. Relieves IVC compression and increases maternal cardiac output by 30–50% [1].
Pediatrics (Infants & Children)
Critical Physiological Difference
Pediatric arrests are predominantly hypoxic/asphyxial (respiratory failure or circulatory shock progressing to bradycardic PEA/asystole) rather than primary ventricular arrhythmias. Cardiac output is strictly heart-rate dependent (CO = HR × SV).
Mandatory Resuscitation & Dosing Modifications
1. Initiate CPR for HR < 60 bpm with signs of poor perfusion despite oxygenation/ventilation.
2. Compression-to-Ventilation Ratio: 15:2 for 2 rescuers (30:2 for single rescuer); compression depth 1/3 AP diameter (4 cm infant, 5 cm child).
3. Defibrillation: 2 J/kg first shock, 4 J/kg second shock, then ≥ 4 J/kg up to 10 J/kg (Max adult dose 200 J).
4. Epinephrine: 0.01 mg/kg (0.1 mL/kg of 0.1 mg/mL [1:10,000]) IV/IO q3–5 min (Max single dose: 1 mg).
5. Amiodarone: 5 mg/kg IV/IO bolus for refractory VF/pVT (Max single dose: 300 mg).
2. Compression-to-Ventilation Ratio: 15:2 for 2 rescuers (30:2 for single rescuer); compression depth 1/3 AP diameter (4 cm infant, 5 cm child).
3. Defibrillation: 2 J/kg first shock, 4 J/kg second shock, then ≥ 4 J/kg up to 10 J/kg (Max adult dose 200 J).
4. Epinephrine: 0.01 mg/kg (0.1 mL/kg of 0.1 mg/mL [1:10,000]) IV/IO q3–5 min (Max single dose: 1 mg).
5. Amiodarone: 5 mg/kg IV/IO bolus for refractory VF/pVT (Max single dose: 300 mg).
Frail Geriatrics (≥ 65 Years)
Critical Physiological Difference
Decreased chest wall compliance (calcified costal cartilages), high prevalence of severe aortic stenosis (fixed LV outflow tract obstruction where CPP depends entirely on high SVR), baseline chronic hypertension (right-shifted cerebral autoregulation curve), and high rate of occult pulmonary embolism or drug toxicity.
Mandatory Resuscitation & Dosing Modifications
1. Anticipate Rib/Sternal Fractures: Maintain full 5 cm depth despite costal cartilage crepitus; monitor POCUS for iatrogenic hemopneumothorax or cardiac laceration.
2. Higher Post-ROSC MAP Target: In patients with chronic poorly controlled hypertension, target a post-ROSC MAP of 75–85 mmHg to prevent watershed cerebral ischemia.
3. Early Goals-of-Care & Frailty Assessment: Verify advance directives/DNAR status early while avoiding premature nihilism in witnessed shockable arrests.
2. Higher Post-ROSC MAP Target: In patients with chronic poorly controlled hypertension, target a post-ROSC MAP of 75–85 mmHg to prevent watershed cerebral ischemia.
3. Early Goals-of-Care & Frailty Assessment: Verify advance directives/DNAR status early while avoiding premature nihilism in witnessed shockable arrests.
| Population | Critical Physiological Difference | Mandatory Resuscitation & Dosing Modifications |
|---|---|---|
| Pregnancy (≥ 20 Weeks Gestation / Fundus at or above Umbilicus) | Gravid uterus compresses the inferior vena cava (IVC) and abdominal aorta in the supine position (aortocaval compression), reducing venous return and cardiac output by up to 60%, rendering standard chest compressions ineffective. | 1. Continuous Manual Left Uterine Displacement (LUD): Pull or push the uterus 15–30° to the left while keeping the thorax flat on the board for optimal compression vector [1]. 2. IV Access Above the Diaphragm: Place IV/IO in upper extremities/humerus; femoral drugs are trapped below the compressed IVC. 3. Early Intubation with Smaller ETT: Airway edema requires a 6.0–6.5 mm ID ETT. 4. Resuscitative Hysterotomy (Perimortem C-Section): Prepare scalpel at Minute 0; incise at Minute 4 to deliver the fetus by Minute 5 if no ROSC. Relieves IVC compression and increases maternal cardiac output by 30–50% [1]. |
| Pediatrics (Infants & Children) | Pediatric arrests are predominantly hypoxic/asphyxial (respiratory failure or circulatory shock progressing to bradycardic PEA/asystole) rather than primary ventricular arrhythmias. Cardiac output is strictly heart-rate dependent (CO = HR × SV). | 1. Initiate CPR for HR < 60 bpm with signs of poor perfusion despite oxygenation/ventilation. 2. Compression-to-Ventilation Ratio: 15:2 for 2 rescuers (30:2 for single rescuer); compression depth 1/3 AP diameter (4 cm infant, 5 cm child). 3. Defibrillation: 2 J/kg first shock, 4 J/kg second shock, then ≥ 4 J/kg up to 10 J/kg (Max adult dose 200 J). 4. Epinephrine: 0.01 mg/kg (0.1 mL/kg of 0.1 mg/mL [1:10,000]) IV/IO q3–5 min (Max single dose: 1 mg). 5. Amiodarone: 5 mg/kg IV/IO bolus for refractory VF/pVT (Max single dose: 300 mg). |
| Frail Geriatrics (≥ 65 Years) | Decreased chest wall compliance (calcified costal cartilages), high prevalence of severe aortic stenosis (fixed LV outflow tract obstruction where CPP depends entirely on high SVR), baseline chronic hypertension (right-shifted cerebral autoregulation curve), and high rate of occult pulmonary embolism or drug toxicity. | 1. Anticipate Rib/Sternal Fractures: Maintain full 5 cm depth despite costal cartilage crepitus; monitor POCUS for iatrogenic hemopneumothorax or cardiac laceration. 2. Higher Post-ROSC MAP Target: In patients with chronic poorly controlled hypertension, target a post-ROSC MAP of 75–85 mmHg to prevent watershed cerebral ischemia. 3. Early Goals-of-Care & Frailty Assessment: Verify advance directives/DNAR status early while avoiding premature nihilism in witnessed shockable arrests. |
⚠ E. “NEVER DO THIS & WHY” (Pathophysiological & Mechanical Counter-Examples)
5 LETHAL RESUSCITATION ERRORS & THEIR EXACT MECHANISM OF HARM
- NEVER administer routine empiric Sodium Bicarbonate (8.4% NaHCO₃) in undifferentiated cardiac arrest. Why (Paradoxical Intracellular Acidosis): Under the Henderson-Hasselbalch equation (H⁺ + HCO₃⁻ ↔ H₂CO₃ ↔ H₂O + CO₂), infused bicarbonate buffers protons by generating dissolved carbon dioxide (CO₂). Because pulmonary blood flow during CPR is only 25% of normal, the lungs cannot clear this CO₂ load. Unlike charged HCO₃⁻ ions (which cross cell membranes slowly), uncharged lipophilic CO₂ rapidly diffuses across the myocardial sarcolemma and blood-brain barrier, re-hydrating inside the cell to form H⁺ and worsening intracellular myocardial and cerebral acidosis, depressing contractility. Reserve NaHCO₃ strictly for hyperkalemia, tricyclic antidepressant (TCA)/sodium-channel blocker overdose, or pre-existing severe normal-anion-gap acidosis [1].
- NEVER administer routine empiric Calcium in undifferentiated PEA or Asystole [COCA Trial]. Why (Ischemic Cytosolic Calcium Overload & mPTP Opening): During global ischemia, failure of ATP-dependent pumps already floods the cardiomyocyte and neuronal cytosol with Ca²⁺. Administering exogenous IV Calcium in the absence of hyperkalemia, hypocalcemia, or calcium-channel blocker toxicity drives massive intracellular Ca²⁺ influx upon reperfusion, triggering mitochondrial permeability transition pore (mPTP) opening, protease/phospholipase activation, neuronal apoptosis, and myocardial hypercontracture (“stone heart”). The randomized COCA Trial (2021) was terminated early for harm, demonstrating a trend toward lower ROSC and worse 30-day survival with empiric calcium [10].
- NEVER hyperventilate the patient during CPR or immediately post-ROSC. Why (Hemodynamic Tamponade & Cerebral Vasoconstriction): Bagging faster than 10 breaths/min during CPR prevents intrathoracic pressure from returning to baseline zero/negative during decompression. This persistently elevated intrathoracic pressure compresses the right atrium (↑ PRA), impedes venous return, and reduces CPP. Furthermore, every 1 mmHg drop in PaCO₂ below 35 mmHg decreases cerebral blood flow (CBF) by 2–3% via pH-mediated arteriolar constriction, worsening post-arrest hypoxic-ischemic brain injury [1,7].
- NEVER pause chest compressions for > 10 seconds to perform endotracheal intubation or POCUS. Why (Loss of the Arterial Windkessel Pressure Gradient): A pause > 10 seconds allows complete runoff of aortic blood volume into the venous capacitance vessels, collapsing PAoD to < 15 mmHg. Every 5-second increase in the perishock pause reduces defibrillation success by nearly 18%. If vocal cords cannot be visualized during continuous compressions via video laryngoscopy, insert a supraglottic airway (i-gel) immediately without pausing CPR [1,2].
- NEVER rush a comatose post-ROSC patient WITHOUT ST-elevation (NSTE-ACS / nonspecific ECG) directly to emergent coronary angiography before stabilizing ICU hemodynamics [COACT & TOMAHAWK Trials]. Why (Competing Risk of Anoxic Brain Injury & Contrast/Procedural Instability): In post-ROSC patients without ST-elevation or OMI equivalents, the primary cause of death is hypoxic-ischemic encephalopathy, not acute coronary thrombosis. Emergent cath lab transport delays targeted temperature control, exposes the stunned myocardium to contrast load, and delays neuroprotective ICU care without improving 30-day or 90-day survival (unless cardiogenic shock or electrical instability is present) [8].
Section 5
2024–2026 Guideline Updates & Landmark Trials
PARAMEDIC2 (Perkins et al., NEJM 2018) [3]
Population & Comparison
N = 8,014 adults with out-of-hospital cardiac arrest (OHCA): Epinephrine 1 mg IV vs. Placebo.
Primary Outcome & Verified Statistics
30-Day Survival: 3.2% (Epinephrine) vs. 2.4% (Placebo) (OR 1.39; p = 0.003). Severe Neurologic Impairment (mRS 4–5): 31.0% vs. 17.8%. No significant difference in favorable neurologic outcome at discharge.
Why the Evidence Shifted Mechanistically
Epinephrine’s α₁ agonism reliably boosts macrovascular PAoD and achieves ROSC (36.3% vs. 11.7%), but intense α₁-mediated constriction of the cerebral microcirculation during CPR impairs cortical capillary blood flow, explaining why hearts restart after prolonged downtime while brains suffer severe hypoxic injury [3].
ALPS (Kudenchuk et al., NEJM 2016) [4]
Population & Comparison
N = 3,026 adults with shock-refractory VF/pVT OHCA: Amiodarone vs. Lidocaine vs. Placebo.
Primary Outcome & Verified Statistics
Survival to Discharge (Overall): 24.4% (Amiodarone) vs. 23.7% (Lidocaine) vs. 21.0% (Placebo) (p = 0.08). Bystander-Witnessed Subgroup: Both Amiodarone (27.7%) and Lidocaine (27.8%) significantly beat Placebo (22.7%, p = 0.01).
Why the Evidence Shifted Mechanistically
Antiarrhythmics only improve survival when administered during the Electrical or early Circulatory phase (witnessed arrests) before irreversible mitochondrial damage occurs. Consequently, AHA/ILCOR guidelines endorse either Amiodarone or Lidocaine as equivalent Class IIb options [1,4].
AIRWAYS-2 (Benger et al., JAMA 2018) [2]
Population & Comparison
N = 9,296 adults with non-traumatic OHCA: Initial Supraglottic Airway (i-gel) vs. Endotracheal Intubation (ETI).
Primary Outcome & Verified Statistics
Favorable Functional Outcome (mRS 0–3 at 30d): 6.4% (i-gel) vs. 6.8% (ETI) (Adjusted RD −0.6%; p = 0.33).
Why the Evidence Shifted Mechanistically
Supraglottic airways achieve rapid oxygenation and capnography monitoring without requiring laryngoscopy-induced pauses in chest compressions, proving non-inferior to ETI when operators lack a > 95% first-pass ETI success rate [2].
DOSE-VF (Cheskes et al., NEJM 2022) [5]
Population & Comparison
N = 405 adults with refractory VF (≥ 3 failed standard shocks): DSED vs. Vector-Change (VC) vs. Standard Defibrillation.
Primary Outcome & Verified Statistics
Survival to Hospital Discharge:
• DSED: 30.4% vs. 13.3% Standard (RR 2.21; 95% CI 1.33–3.67).
• VC: 21.7% vs. 13.3% Standard (RR 1.71; 95% CI 1.01–2.88).
• DSED: 30.4% vs. 13.3% Standard (RR 2.21; 95% CI 1.33–3.67).
• VC: 21.7% vs. 13.3% Standard (RR 1.71; 95% CI 1.01–2.88).
Why the Evidence Shifted Mechanistically
Standard anterolateral pads frequently miss the posterior-inferior left ventricle where fibrillatory wavelets persist. Shifting the vector (AP) or delivering sequential overlapping shocks increases intracardiac voltage gradient across the entire LV mass, terminating refractory VF [5].
ARREST (Yannopoulos et al., Lancet 2020) [6]
Population & Comparison
N = 30 adults with refractory VF/pVT OHCA (≥ 3 shocks): Early ECPR (VA-ECMO) vs. Standard ACLS.
Primary Outcome & Verified Statistics
Survival to Hospital Discharge: 43% (ECPR) vs. 7% (Standard ACLS) (Posterior probability 0.986; stopped early by DSMB for overwhelming efficacy).
Why the Evidence Shifted Mechanistically
Extracorporeal membrane oxygenation immediately restores 4–5 L/min of oxygenated systemic and coronary perfusion, bypassing the stunned myocardium, clearing metabolic acidosis, and allowing controlled coronary revascularization in the cath lab [6].
TOMAHAWK (Desch et al., NEJM 2021) [8]
Population & Comparison
N = 554 resuscitated OHCA patients without ST-segment elevation on post-ROSC ECG: Immediate vs. Delayed/Selective Coronary Angiography.
Primary Outcome & Verified Statistics
30-Day All-Cause Mortality: 54.0% (Immediate Angiography) vs. 46.0% (Delayed/Selective) (HR 1.28; 95% CI 1.00–1.63; p = 0.06). Confirming COACT (2019).
Why the Evidence Shifted Mechanistically
Only ~15–20% of post-ROSC patients without ST-elevation have an acute culprit coronary lesion; the majority die of neurological injury. Immediate cath lab transfer offers no mortality benefit unless STEMI/OMI, cardiogenic shock, or electrical instability is present [8].
TTM2 (Dankiewicz et al., NEJM 2021) [9]
Population & Comparison
N = 1,900 comatose adults post-OHCA: Targeted Hypothermia (33°C) vs. Targeted Normothermia with strict fever avoidance (≤ 37.5°C).
Primary Outcome & Verified Statistics
6-Month All-Cause Mortality: 50% (33°C) vs. 48% (Normothermia) (RR 1.04; p = 0.37). Arrhythmias with Hemodynamic Compromise: 24% (33°C) vs. 17% (Normothermia) (p < 0.001).
Why the Evidence Shifted Mechanistically
The neuroprotective benefit previously attributed to deep hypothermia (32–34°C) is primarily driven by active prevention of hyperthermia/fever (> 37.7°C), avoiding hypothermia-induced bradyarrhythmias, coagulopathy, and electrolyte shifts [7,9].
COCA (Vallentin et al., JAMA 2021) [10]
Population & Comparison
N = 397 adults with OHCA: Empiric IV/IO Calcium Chloride (5 mmol) vs. Saline Placebo.
Primary Outcome & Verified Statistics
Sustained ROSC: 19% (Calcium) vs. 27% (Placebo) (RR 0.72; p = 0.09).
30-Day Survival: 5.2% vs. 9.1% (Stopped early for harm).
30-Day Survival: 5.2% vs. 9.1% (Stopped early for harm).
Why the Evidence Shifted Mechanistically
Exogenous calcium during global ischemia exacerbates cytosolic Ca²⁺ overload, triggering mitochondrial injury and myocardial hypercontracture without improving defibrillation or contractility [10].
| Trial / Guideline | Population & Comparison | Primary Outcome & Verified Statistics | Why the Evidence Shifted Mechanistically |
|---|---|---|---|
| PARAMEDIC2 (Perkins et al., NEJM 2018) [3] | N = 8,014 adults with out-of-hospital cardiac arrest (OHCA): Epinephrine 1 mg IV vs. Placebo. | 30-Day Survival: 3.2% (Epinephrine) vs. 2.4% (Placebo) (OR 1.39; p = 0.003). Severe Neurologic Impairment (mRS 4–5): 31.0% vs. 17.8%. No significant difference in favorable neurologic outcome at discharge. | Epinephrine’s α₁ agonism reliably boosts macrovascular PAoD and achieves ROSC (36.3% vs. 11.7%), but intense α₁-mediated constriction of the cerebral microcirculation during CPR impairs cortical capillary blood flow, explaining why hearts restart after prolonged downtime while brains suffer severe hypoxic injury [3]. |
| ALPS (Kudenchuk et al., NEJM 2016) [4] | N = 3,026 adults with shock-refractory VF/pVT OHCA: Amiodarone vs. Lidocaine vs. Placebo. | Survival to Discharge (Overall): 24.4% (Amiodarone) vs. 23.7% (Lidocaine) vs. 21.0% (Placebo) (p = 0.08). Bystander-Witnessed Subgroup: Both Amiodarone (27.7%) and Lidocaine (27.8%) significantly beat Placebo (22.7%, p = 0.01). | Antiarrhythmics only improve survival when administered during the Electrical or early Circulatory phase (witnessed arrests) before irreversible mitochondrial damage occurs. Consequently, AHA/ILCOR guidelines endorse either Amiodarone or Lidocaine as equivalent Class IIb options [1,4]. |
| AIRWAYS-2 (Benger et al., JAMA 2018) [2] | N = 9,296 adults with non-traumatic OHCA: Initial Supraglottic Airway (i-gel) vs. Endotracheal Intubation (ETI). | Favorable Functional Outcome (mRS 0–3 at 30d): 6.4% (i-gel) vs. 6.8% (ETI) (Adjusted RD −0.6%; p = 0.33). | Supraglottic airways achieve rapid oxygenation and capnography monitoring without requiring laryngoscopy-induced pauses in chest compressions, proving non-inferior to ETI when operators lack a > 95% first-pass ETI success rate [2]. |
| DOSE-VF (Cheskes et al., NEJM 2022) [5] | N = 405 adults with refractory VF (≥ 3 failed standard shocks): DSED vs. Vector-Change (VC) vs. Standard Defibrillation. | Survival to Hospital Discharge: • DSED: 30.4% vs. 13.3% Standard (RR 2.21; 95% CI 1.33–3.67). • VC: 21.7% vs. 13.3% Standard (RR 1.71; 95% CI 1.01–2.88). | Standard anterolateral pads frequently miss the posterior-inferior left ventricle where fibrillatory wavelets persist. Shifting the vector (AP) or delivering sequential overlapping shocks increases intracardiac voltage gradient across the entire LV mass, terminating refractory VF [5]. |
| ARREST (Yannopoulos et al., Lancet 2020) [6] | N = 30 adults with refractory VF/pVT OHCA (≥ 3 shocks): Early ECPR (VA-ECMO) vs. Standard ACLS. | Survival to Hospital Discharge: 43% (ECPR) vs. 7% (Standard ACLS) (Posterior probability 0.986; stopped early by DSMB for overwhelming efficacy). | Extracorporeal membrane oxygenation immediately restores 4–5 L/min of oxygenated systemic and coronary perfusion, bypassing the stunned myocardium, clearing metabolic acidosis, and allowing controlled coronary revascularization in the cath lab [6]. |
| TOMAHAWK (Desch et al., NEJM 2021) [8] | N = 554 resuscitated OHCA patients without ST-segment elevation on post-ROSC ECG: Immediate vs. Delayed/Selective Coronary Angiography. | 30-Day All-Cause Mortality: 54.0% (Immediate Angiography) vs. 46.0% (Delayed/Selective) (HR 1.28; 95% CI 1.00–1.63; p = 0.06). Confirming COACT (2019). | Only ~15–20% of post-ROSC patients without ST-elevation have an acute culprit coronary lesion; the majority die of neurological injury. Immediate cath lab transfer offers no mortality benefit unless STEMI/OMI, cardiogenic shock, or electrical instability is present [8]. |
| TTM2 (Dankiewicz et al., NEJM 2021) [9] | N = 1,900 comatose adults post-OHCA: Targeted Hypothermia (33°C) vs. Targeted Normothermia with strict fever avoidance (≤ 37.5°C). | 6-Month All-Cause Mortality: 50% (33°C) vs. 48% (Normothermia) (RR 1.04; p = 0.37). Arrhythmias with Hemodynamic Compromise: 24% (33°C) vs. 17% (Normothermia) (p < 0.001). | The neuroprotective benefit previously attributed to deep hypothermia (32–34°C) is primarily driven by active prevention of hyperthermia/fever (> 37.7°C), avoiding hypothermia-induced bradyarrhythmias, coagulopathy, and electrolyte shifts [7,9]. |
| COCA (Vallentin et al., JAMA 2021) [10] | N = 397 adults with OHCA: Empiric IV/IO Calcium Chloride (5 mmol) vs. Saline Placebo. | Sustained ROSC: 19% (Calcium) vs. 27% (Placebo) (RR 0.72; p = 0.09). 30-Day Survival: 5.2% vs. 9.1% (Stopped early for harm). | Exogenous calcium during global ischemia exacerbates cytosolic Ca²⁺ overload, triggering mitochondrial injury and myocardial hypercontracture without improving defibrillation or contractility [10]. |
Section 6
Disposition, Program Director KPIs & Structured SBAR Handover
A. Disposition & ICU Escalation Criteria
- Immediate Cardiac Catheterization Lab (Direct Bypass of ICU): All post-ROSC patients (awake or comatose) with STEMI or OMI equivalents on 12-lead ECG, or post-ROSC patients without ST-elevation who exhibit persistent cardiogenic shock, recurrent malignant ventricular arrhythmias (VF/pVT), or ECPR cannulation [7,8].
- Coronary Care Unit (CCU) / Medical Intensive Care Unit (MICU): All comatose post-ROSC survivors (GCS < 8 or unable to follow commands) after exclusion of STEMI and intracranial hemorrhage (via CT Head) for invasive arterial/central venous monitoring, lung-protective ventilation, and active temperature control (≤ 37.5°C) [7,9].
- Termination of Resuscitation (TOR) Criteria in the ED: Consider termination when all of the following are met (and reversible causes—specifically hypothermia, toxic overdose, and massive PE—are excluded): Unwitnessed arrest, non-shockable rhythm throughout resuscitation, no ROSC prior to ED arrival, persistent ETCO₂ < 10 mmHg after ≥ 20 minutes of high-quality ACLS, and complete cardiac standstill on serial CASA POCUS examinations [1].
B. Program Director’s Quality KPIs, Accreditation (JCI / CBAHI / GAHAR / Ada’a) & M&M Audit Points
- Chest Compression Fraction (CCF): Must exceed > 80% across the entire resuscitation (monitored via defibrillator impedance/accelerometer pads) [1].
- Time to First Defibrillation (In-Hospital / ED Arrest): ≤ 2 minutes from recognition of VF/pVT [1].
- Perishock Pause Duration: Pre-shock pause < 5 seconds; total perishock pause < 10 seconds.
- Time to First Epinephrine in Non-Shockable Arrest (PEA/Asystole): ≤ 3 minutes from arrest recognition [1,3].
- Post-ROSC 12-Lead ECG Acquisition: ≤ 5 minutes from sustained ROSC; Door/ROSC-to-Balloon Time ≤ 90 minutes for STEMI [7].
- Neuroprognostication Delay Mandate (M&M Audit Trap): Zero withdrawal of life-sustaining therapy (WLST) for perceived poor neurological prognosis prior to ≥ 72 hours after ROSC and return to normothermia (and full clearance of sedatives/neuromuscular blockers) [7].
C. Structured Clinical SBAR Handover (ED Consultant to Interventional Cardiology & ICU Consultant)
S
Situation: “Doctor, I am calling from Resuscitation Bay 1 with an emergent handover and Cath Lab activation for a 54-year-old male who suffered a witnessed out-of-hospital Ventricular Fibrillation arrest and achieved sustained ROSC 12 minutes ago with an anterior STEMI on post-ROSC ECG.”
Background: “He collapsed at home after 30 minutes of substernal chest pain. Bystander CPR was started immediately. EMS arrived at 6 minutes, shocked VF twice, and transported. In our ED, he remained in refractory VF after Shock #3; we administered Epinephrine 1 mg IV, Amiodarone 300 mg IV, and performed Double Sequential External Defibrillation (200 J AL + 200 J AP), achieving ROSC at total downtime of 18 minutes.”
Assessment: “Airway is secured with a 7.5 mm ETT at 22 cm at the teeth; he is ventilated on Volume Control (VT 450 mL, RR 14, PEEP 5, FiO₂ 50%) with SpO₂ 96% and ETCO₂ 38 mmHg. Hemodynamically, his BP is 98/64 mmHg (MAP 75 mmHg) on Norepinephrine at 0.1 mcg/kg/min (30 mL/hr). 12-lead ECG shows 4 mm tombstoning ST elevations in V1–V4 with reciprocal depressions in II, III, and aVF. Bedside POCUS shows an anterior wall motion abnormality with an estimated LVEF of 30% and no pericardial effusion. Arterial blood gas shows pH 7.21, PaCO₂ 40 mmHg, PaO₂ 88 mmHg, K⁺ 4.1 mmol/L, and Lactate 6.8 mmol/L. Core temperature is 36.1°C; he is sedated on Propofol and Fentanyl.”
Recommendation: “He requires immediate transfer to the Cardiac Catheterization Lab for primary PCI of the left anterior descending (LAD) artery, followed by ICU admission for invasive hemodynamic monitoring, Amiodarone maintenance infusion (1 mg/min for 6 hours), and targeted temperature control to strictly prevent fever (≤ 37.5°C).”
Section 7
Clinical Pitfalls, Board Exam Rapid-Fire Traps & Interactive Simulator
A. 3 Senior Consultant Bedside Pearls
- Beware the “Lazarus Phenomenon” (Auto-PEEP Pseudo-PEA): In patients with severe asthma/COPD (or any patient hyperventilated with a BVM during CPR), incomplete exhalation traps massive intrathoracic air volume (dynamic hyperinflation / Auto-PEEP). This tamponades the right atrium and vena cava completely, producing a flat arterial line and impalpable pulse despite an organized electrical rhythm. Before calling Termination of Resuscitation in a PEA patient, disconnect the BVM from the endotracheal tube for 30 to 60 seconds and apply gentle bilateral chest wall pressure— relief of intrathoracic pressure frequently restores venous return and spontaneous circulation immediately.
- Distinguish True PEA from Pseudo-PEA via Femoral Arterial Line & POCUS: Manual carotid pulse palpation during a 10-second rhythm check is notoriously inaccurate (up to 45% error rate when systolic BP is < 60 mmHg). If CASA POCUS demonstrates organized ventricular contractility with aortic valve opening despite absent palpable pulses (Pseudo-PEA), the patient is in profound shock, not true cardiac arrest. Administer push-dose Epinephrine (10–20 mcg IV) and synchronize compressions or transition to high-dose vasopressor titration rather than treating as mechanical standstill.
- Never Trust Pupillary Reactivity or Myoclonus in the First 24 Hours: High-dose intra-arrest Epinephrine and Atropine dilate pupils pharmacologically, while therapeutic sedation obscures brainstem reflexes. Furthermore, early post-ROSC status myoclonus (including Lance-Adams syndrome) does not equate to a 100% fatal prognosis; multimodal neuroprognostication (pupillometry, corneal reflexes, SSEP N20 waves, EEG, NSE, and MRI brain) is strictly forbidden before 72 hours post-ROSC [7].
B. Board Exam Rapid-Fire Traps Table (SCFHS / Arab Board / MRCEM / ABEM)
Comatose 62-year-old post-ROSC after VF arrest; 12-lead ECG shows diffuse ST depressions and RBBB, NO ST-segment elevation; BP 105/65 mmHg on low-dose Norepinephrine.
The Common Distractor Trap
Activate the Cardiac Catheterization Lab immediately for emergent (< 90 min) coronary angiography.
The Correct Board Answer & Mechanism
Admit to ICU for Targeted Temperature Control (≤ 37.5°C), hemodynamic optimization, and delayed/selective angiography. Per the COACT and TOMAHAWK trials, immediate angiography in hemodynamically stable post-ROSC patients without ST-elevation offers zero mortality benefit [8].
Dialysis patient misses 2 sessions, suffers PEA arrest with wide, bizarre sine-wave QRS complexes on rhythm strip.
The Common Distractor Trap
Administer Amiodarone 300 mg IV bolus or synchronize cardioversion for wide-complex tachycardia.
The Correct Board Answer & Mechanism
Administer Calcium Chloride 10% 10 mL (1 g) IV push + Sodium Bicarbonate 50 mEq IV. Severe hyperkalemia inactivates fast Na⁺ channels; Amiodarone (Na⁺/K⁺ blocker) will precipitate irreversible asystole. Calcium immediately restores the myocardial excitability threshold [1].
Intubated patient in PEA arrest for 15 minutes; ETCO₂ has been steady at 14 mmHg, then suddenly jumps to 42 mmHg mid-cycle.
The Common Distractor Trap
Administer another 1 mg Epinephrine IV and increase respiratory rate to 20 breaths/min to “blow off the CO₂.”
The Correct Board Answer & Mechanism
Continue compressions until the end of the 2-minute cycle (or check pulse/arterial waveform) to confirm ROSC; DO NOT hyperventilate. An abrupt jump in ETCO₂ > 35–40 mmHg signifies a sudden surge in pulmonary blood flow (ROSC) returning tissue CO₂ to the alveoli [1].
32-week pregnant female in traumatic/medical PEA arrest; CPR ongoing for 4 minutes with no ROSC despite Left Uterine Displacement.
The Common Distractor Trap
Transport immediately to the Obstetric Operating Theater for fetal monitoring and cesarean section.
The Correct Board Answer & Mechanism
Perform immediate bedside Resuscitative Hysterotomy (Perimortem C-Section) in the ED at Minute 4 (deliver by Minute 5). Transporting wastes critical minutes; bedside uterine evacuation relieves aortocaval compression and restores maternal venous return [1].
| Exam Stem Clue | The Common Distractor Trap | The Correct Board Answer & Mechanism |
|---|---|---|
| Comatose 62-year-old post-ROSC after VF arrest; 12-lead ECG shows diffuse ST depressions and RBBB, NO ST-segment elevation; BP 105/65 mmHg on low-dose Norepinephrine. | Activate the Cardiac Catheterization Lab immediately for emergent (< 90 min) coronary angiography. | Admit to ICU for Targeted Temperature Control (≤ 37.5°C), hemodynamic optimization, and delayed/selective angiography. Per the COACT and TOMAHAWK trials, immediate angiography in hemodynamically stable post-ROSC patients without ST-elevation offers zero mortality benefit [8]. |
| Dialysis patient misses 2 sessions, suffers PEA arrest with wide, bizarre sine-wave QRS complexes on rhythm strip. | Administer Amiodarone 300 mg IV bolus or synchronize cardioversion for wide-complex tachycardia. | Administer Calcium Chloride 10% 10 mL (1 g) IV push + Sodium Bicarbonate 50 mEq IV. Severe hyperkalemia inactivates fast Na⁺ channels; Amiodarone (Na⁺/K⁺ blocker) will precipitate irreversible asystole. Calcium immediately restores the myocardial excitability threshold [1]. |
| Intubated patient in PEA arrest for 15 minutes; ETCO₂ has been steady at 14 mmHg, then suddenly jumps to 42 mmHg mid-cycle. | Administer another 1 mg Epinephrine IV and increase respiratory rate to 20 breaths/min to “blow off the CO₂.” | Continue compressions until the end of the 2-minute cycle (or check pulse/arterial waveform) to confirm ROSC; DO NOT hyperventilate. An abrupt jump in ETCO₂ > 35–40 mmHg signifies a sudden surge in pulmonary blood flow (ROSC) returning tissue CO₂ to the alveoli [1]. |
| 32-week pregnant female in traumatic/medical PEA arrest; CPR ongoing for 4 minutes with no ROSC despite Left Uterine Displacement. | Transport immediately to the Obstetric Operating Theater for fetal monitoring and cesarean section. | Perform immediate bedside Resuscitative Hysterotomy (Perimortem C-Section) in the ED at Minute 4 (deliver by Minute 5). Transporting wastes critical minutes; bedside uterine evacuation relieves aortocaval compression and restores maternal venous return [1]. |
C. Interactive Clinical Simulator Decision Matrix
BEDSIDE CLINICAL SIMULATOR: THE REFRACTORY VF → POST-ROSC CASCADE
SCENARIO STEM
A 48-year-old male collapses in the ED waiting room. He is pulseless and apneic. Monitor shows coarse Ventricular Fibrillation (VF). High-quality CPR is started; i-gel size 4 and 18G antecubital IV are placed.
↓
NODE 1: MINUTE 4 — SHOCK #3 DELIVERED (200 J Biphasic)
Patient remains in coarse VF. Epinephrine 1 mg IV was given at Minute 2. What is your immediate pharmacologic and electrical sequence?
OPTION A (Clinical Failure): Give Calcium Chloride 1 g IV + Shock #4 at 200 J in standard pads.
Outcome: Empiric calcium worsens cytosolic Ca²⁺ overload (COCA Trial). Standard pad vector continues to miss the posterior LV.
OPTION B (Correct Action): Give Amiodarone 300 mg IV bolus + Prepare Double Sequential External Defibrillation (DSED: AL + AP pads) for Shock #4 [DOSE-VF].
Outcome: Captures posterior LV fibers → Proceed to Node 2.
↓
NODE 2: MINUTE 6 — DSED DELIVERED & ROSC ACHIEVED
Mid-cycle, ETCO₂ jumps from 16 mmHg to 44 mmHg. At rhythm check, organized narrow-complex rhythm at 94 bpm with a strong carotid pulse is confirmed (ROSC). BP is 68/40 mmHg (MAP 49 mmHg). SpO₂ is 100% on FiO₂ 1.0. 12-lead ECG shows 2 mm ST-depression in V4–V6 without ST-elevation or OMI morphology. What is your immediate 3-step post-ROSC stabilization bundle?
OPTION A (Clinical Failure): Rush straight to Cath Lab without vasopressors; keep FiO₂ at 100% and bag at 22 breaths/min to correct metabolic acidosis.
Outcome: Hypotension + hypocapnic cerebral vasoconstriction + hyperoxic free-radical injury cause devastating anoxic brain injury (violates TOMAHAWK & AHA Post-ROSC guidelines).
OPTION B (Optimal Survival): Give Push-Dose Epinephrine 10 mcg IV while starting Norepinephrine infusion (target MAP ≥ 65–75 mmHg); titrate FiO₂ to SpO₂ 92–98% and RR to PaCO₂ 35–45 mmHg; obtain CT Head/CTPA and admit to ICU for TTM (≤ 37.5°C).
Outcome: Cerebral perfusion pressure preserved; secondary brain injury prevented.
Section 8
Board Viva, OSCE Station Rubric & Resident Self-Assessment
A. OSCE & Oral Board Examiner Rubric (Topic 1.1)
To achieve a Pass / Distinction rating on a High-Fidelity Resuscitation OSCE Station, the candidate must execute and verbalize the following 4 critical milestones:
- High-Performance CPR Mechanics & Perishock Pause Control: Assigns roles clearly, enforces a metronome/feedback rate of 100–120/min with full recoil, pre-charges the defibrillator at 1:45 of the cycle, and ensures the perishock pause is strictly < 5 seconds [1].
- Waveform Capnography Integration & Airway Discipline: Inserts an i-gel or intubates without pausing compressions, connects waveform ETCO₂ immediately, sets ventilation strictly to 10 breaths/min, and verbalizes ETCO₂ > 10 mmHg as the resuscitation quality target [1,2].
- Systematic H’s & T’s + Refractory VF Escalation: Administers Epinephrine (1 mg) after Shock #2 and Amiodarone (300 mg) after Shock #3; correctly deploys CASA POCUS during a < 10 s pulse check and verbalizes Vector-Change (AP) or DSED for refractory VF [1,4,5].
- Neuroprotective Post-ROSC Bundle: Immediately orders a 12-lead ECG, arterial blood gas, and Norepinephrine infusion (MAP ≥ 65 mmHg); down-titrates FiO₂ to target SpO₂ 92–98%, adjusts minute ventilation to PaCO₂ 35–45 mmHg, and initiates active fever prevention (≤ 37.5°C) [7,9].
B. 2 Board-Style Clinical Vignette MCQs (SCFHS / MRCEM / ABEM Level)
Vignette 1: A 59-year-old male experiences a witnessed collapse in the Emergency Department triage area. Chest compressions are initiated immediately, and defibrillator pads placed in the standard anterolateral position reveal coarse ventricular fibrillation. Over the next 6 minutes, he receives three biphasic defibrillation shocks (200 J each), high-quality CPR with a compression fraction of 88%, supraglottic airway placement (ETCO₂ 22 mmHg), Epinephrine 1 mg IV, and Amiodarone 300 mg IV. At the fourth rhythm check, he remains in high-amplitude ventricular fibrillation. According to the landmark DOSE-VF trial and recent resuscitation updates, which of the following interventions is most likely to terminate his refractory ventricular fibrillation and improve survival to hospital discharge?
- A. Administer Calcium Chloride 1 g IV and Sodium Bicarbonate 50 mEq IV prior to delivering a fourth standard 200 J shock.
- B. Apply a second set of defibrillator pads in the anteroposterior position and perform Double Sequential External Defibrillation (DSED) with a < 1 second delay between shocks.
- C. Administer Magnesium Sulfate 4 g IV push and switch to synchronized cardioversion at 200 J.
- D. Pause chest compressions for 25 seconds to replace the supraglottic airway with an endotracheal tube before delivering the next shock.
Correct Answer: B.
Mechanism & Explanation: In the DOSE-VF randomized trial (Cheskes et al., NEJM 2022), patients with refractory VF (≥ 3 failed standard shocks) randomized to Double Sequential External Defibrillation (DSED) achieved more than double the survival to hospital discharge compared to standard anterolateral defibrillation (30.4% vs. 13.3%; RR 2.21) [5]. Vector-change (AP) or sequential dual-vector shocks capture the posterior left ventricular myocardium where fibrillating wavelets evade standard anterolateral current pathways. Why Distractors Fail: A is incorrect because empiric calcium (COCA Trial) and bicarbonate cause cytosolic Ca²⁺ overload and paradoxical intracellular acidosis without improving VF termination [1,10]. C is incorrect because Magnesium is only indicated for polymorphic VT associated with a prolonged QT interval (Torsades de Pointes), and synchronized cardioversion will not fire on chaotic VF [1]. D is incorrect because the AIRWAYS-2 trial proved supraglottic airways are non-inferior to ETI, and a 25-second pause destroys coronary perfusion pressure (CPP) [2].
Vignette 2: A 67-year-old female with a history of hypertension and type 2 diabetes achieves Return of Spontaneous Circulation (ROSC) after 14 minutes of resuscitation for a pulseless electrical activity (PEA) arrest. She is intubated and mechanically ventilated, remaining comatose (GCS 3, pupils 3 mm sluggishly reactive). Her vital signs are: BP 112/70 mmHg (MAP 84 mmHg) on Norepinephrine 0.08 mcg/kg/min, HR 88 bpm, SpO₂ 100% on FiO₂ 1.0, and rectal temperature 36.6°C. Post-ROSC 12-lead ECG reveals sinus rhythm with left ventricular hypertrophy and 1 mm horizontal ST depressions in leads V5–V6, without ST-segment elevation. Arterial blood gas reveals pH 7.28, PaCO₂ 26 mmHg, PaO₂ 340 mmHg, and HCO₃⁻ 15 mEq/L. Which of the following is the most appropriate immediate management strategy?
- A. Maintain the current ventilator settings to compensate for the metabolic acidosis, and activate the cath lab for immediate (< 60 min) coronary angiography.
- B. Decrease the respiratory rate to target PaCO₂ 35–45 mmHg, decrease FiO₂ to target SpO₂ 92–98%, and admit to the ICU for active temperature control (≤ 37.5°C) without immediate coronary angiography.
- C. Administer chilled 4°C Normal Saline 2,000 mL IV bolus to rapidly induce hypothermia to 31°C.
- D. Perform immediate bedside neuroprognostication and counsel the family on withdrawal of life-sustaining therapy due to absent motor response.
Correct Answer: B.
Mechanism & Explanation: This patient exhibits severe hyperoxia (PaO₂ 340 mmHg) and hypocapnia (PaCO₂ 26 mmHg), both of which independently worsen post-cardiac arrest brain injury. Hyperoxia amplifies mitochondrial reactive oxygen species (ROS) lipid peroxidation, while hypocapnia (PaCO₂ < 35 mmHg) induces severe cerebral arteriolar vasoconstriction, starving the ischemic penumbra of blood flow [7]. Per the TOMAHAWK and COACT trials, hemodynamically stable post-ROSC patients without ST-elevation do not benefit from immediate coronary angiography [8]. Per the TTM2 trial, active temperature control preventing fever (≤ 37.5°C) is equivalent to hypothermia at 33°C with fewer arrhythmias [9]. Why Distractors Fail: A exacerbates cerebral ischemia via hypocapnic vasoconstriction and exposes the patient to unnecessary immediate angiography. C is contraindicated because rapid prehospital/ED cold IV fluid boluses increase rearrest and pulmonary edema without survival benefit. D violates international guidelines requiring at least 72 hours post-ROSC before neuroprognostication [7].
Section 9
Master List of Abbreviations Used in This Topic
- ABG
- Arterial Blood Gas
- ACLS
- Advanced Cardiovascular Life Support
- AL / AP
- Anterolateral / Anteroposterior
- CASA
- Cardiac Arrest Sonographic Assessment
- CBF
- Cerebral Blood Flow
- CCF
- Chest Compression Fraction
- CMRO₂
- Cerebral Metabolic Rate of Oxygen
- CO
- Cardiac Output
- CPP
- Coronary Perfusion Pressure
- CPR
- Cardiopulmonary Resuscitation
- DAPT
- Dual Antiplatelet Therapy
- DSED
- Double Sequential External Defibrillation
- EADs
- Early Afterdepolarizations
- ECPR
- Extracorporeal CPR
- ETCO₂
- End-Tidal Carbon Dioxide
- ETI
- Endotracheal Intubation
- IBW
- Ideal Body Weight
- ICP
- Intracranial Pressure
- IO
- Intraosseous
- IVC
- Inferior Vena Cava
- LQTS
- Long QT Syndrome
- LUD
- Left Uterine Displacement
- LVEF
- Left Ventricular Ejection Fraction
- MAP
- Mean Arterial Pressure
- mPTP
- Mitochondrial Permeability Transition Pore
- mRS
- Modified Rankin Scale
- MVO₂
- Myocardial Oxygen Consumption
- NCX
- Na⁺/Ca²⁺ Exchanger
- NMDA
- N-Methyl-D-Aspartate
- NSE
- Neuron-Specific Enolase
- OHCA
- Out-of-Hospital Cardiac Arrest
- OMI
- Occlusion Myocardial Infarction
- PAoD
- Aortic Diastolic Pressure
- PCAS
- Post-Cardiac Arrest Syndrome
- PCI
- Percutaneous Coronary Intervention
- PE
- Pulmonary Embolism
- PEA
- Pulseless Electrical Activity
- PEEP
- Positive End-Expiratory Pressure
- POCUS
- Point-of-Care Ultrasound
- PRA
- Right Atrial Diastolic Pressure
- pVT
- Pulseless Ventricular Tachycardia
- ROS
- Reactive Oxygen Species
- ROSC
- Return of Spontaneous Circulation
- RVOT
- Right Ventricular Outflow Tract
- SAH
- Subarachnoid Hemorrhage
- SGA
- Supraglottic Airway
- SSEP
- Somatosensory Evoked Potentials
- STEMI
- ST-Elevation Myocardial Infarction
- SVR
- Systemic Vascular Resistance
- TdP
- Torsades de Pointes
- TOR
- Termination of Resuscitation
- TTM
- Targeted Temperature Management
- VA-ECMO
- Veno-Arterial ECMO
- VBG
- Venous Blood Gas
- VC
- Vector-Change Defibrillation
- VF
- Ventricular Fibrillation
- WLST
- Withdrawal of Life-Sustaining Therapy
Section 10
Landmark References & Clinical Practice Guidelines
- Panchal AR, Bartos JA, Cabañas JG, Donnino MW, Drennan IR, Hirsch KG, et al. Part 3: Adult Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(16_suppl_2):S366–S468. doi:10.1161/CIR.0000000000000916.
- Benger JR, Kirby K, Black S, Brett SJ, Clout M, Lazaroo MJ, et al. Effect of a Strategy of a Supraglottic Airway Device vs Tracheal Intubation During Out-of-Hospital Cardiac Arrest on Functional Outcome: The AIRWAYS-2 Randomized Clinical Trial. JAMA. 2018;320(8):779–791. doi:10.1001/jama.2018.11597.
- Perkins GD, Ji C, Deakin CD, Quinn T, Nolan JP, Scomparin C, et al. A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest (PARAMEDIC2). N Engl J Med. 2018;379(8):711–721. doi:10.1056/NEJMoa1806842.
- Kudenchuk PJ, Brown SP, Daya M, Rea T, Nichol G, Morrison LJ, et al. Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest (ALPS). N Engl J Med. 2016;374(18):1711–1722. doi:10.1056/NEJMoa1514204.
- Cheskes S, Verbeek PR, Drennan IR, McLeod SL, Turner L, Pinto R, et al. Defibrillation Strategies for Refractory Ventricular Fibrillation (DOSE-VF). N Engl J Med. 2022;387(21):1947–1956. doi:10.1056/NEJMoa2207304.
- Yannopoulos D, Bartos J, Raveendran G, Walser E, Connett J, Murray TA, et al. Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial. Lancet. 2020;396(10265):1807–1816. doi:10.1016/S0140-6736(20)32338-2.
- Nolan JP, Sandroni C, Böttiger BW, Cariou A, Cronberg T, Friberg H, et al. European Resuscitation Council and European Society of Intensive Care Medicine Guidelines 2021: Post-resuscitation care. Intensive Care Med. 2021;47(4):369–421. doi:10.1007/s00134-021-06368-4.
- Desch S, Freund A, Akin I, Behnes M, Preusch MR, Zelniker TA, et al. Angiography after Out-of-Hospital Cardiac Arrest without ST-Segment Elevation (TOMAHAWK). N Engl J Med. 2021;385(27):2544–2553. doi:10.1056/NEJMoa2101909.
- Dankiewicz J, Cronberg T, Lilja G, Jakobsen JC, Levin H, Ullén S, et al. Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest (TTM2). N Engl J Med. 2021;384(24):2283–2294. doi:10.1056/NEJMoa2100591.
- Vallentin MF, Granfeldt A, Meilandt C, Povlsen AL, Sindberg B, Holmberg MJ, et al. Effect of Intravenous or Intraosseous Calcium vs Saline on Return of Spontaneous Circulation in Adults With Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial (COCA). JAMA. 2021;326(22):2268–2276. doi:10.1001/jama.2021.20929.